PAVmed Inc. (PAVM)
PAVmed Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
PAVmed Inc. (PAVM) is a Medical - Devices company based in US with a market capitalization of $3.3M. Revenue declined 97.6% year-over-year and free cash flow was negative at -$5.2B. This page tracks PAVM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 39 employees · IPO Jul 27, 2016
Valuation
Valuation & price
$6.53 · as of May 17, 2026 · -63.9% vs 52w high
10.9
P/E ratio
Latest-FY diluted EPS
0.10
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$3.3M
Market cap
-97.6%
Revenue growth (YoY)
-354.9%
Gross margin
-$5.2B
Free cash flow (USD)
$11.8M
Net debt
108.0%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-4.42)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is PAVmed Inc.'s market cap?
PAVmed Inc. (PAVM) has a market capitalization of $3.3M.
What is PAVM's P/E ratio?
PAVM trades at a price-to-earnings ratio of 10.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is PAVM's price-to-book (P/B) ratio?
PAVM trades at 0.10 times book value per share.
When did PAVmed Inc. last report earnings?
PAVM last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying PAVM stock?
SEC Form 4 filings show no open-market insider buys at PAVmed Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Devices
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.